Aiming For More Deals, Shire Christens Regenerative Medicine Unit
The company hopes its newest division will mirror the growth of its rare disease unit, which was built largely through aggressive business development.
The company hopes its newest division will mirror the growth of its rare disease unit, which was built largely through aggressive business development.